Technical Analysis for FARN - Faron Pharmaceuticals Oy
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 117.50 | -0.42% | -0.50 |
FARN closed down 0.42 percent on Friday, April 19, 2024, on 12 percent of normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| Lizard Bullish | Bullish Day Trade Setup | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Doji - Bullish? | Reversal | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | -0.42% | |
| New 52 Week Low | Weakness | -0.42% |
| Alert | Time |
|---|---|
| Lower Bollinger Band Support | about 11 hours ago |
| Fell Below Previous Day's Low | about 12 hours ago |
| Down 3% | about 12 hours ago |
| New 52 Week Low | about 12 hours ago |
| Down 2% | about 14 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Faron Pharmaceuticals Oy is a Finland-based biopharmaceutical company engaged in the biotechnology and medical research industry. The Company develops late stage clinical drugs focusing on acute organ traumas, cancer immunotherapy and vascular damage. Its product pipeline includes Traumakine (FP-1201-lyo), an Acute Respiratory Distress Syndrome (ARDS) treatment that is in phase Three development; and Clevegen (FP-1304), an anti-Clever-1 immunotheraphy tumor targeting candidate that is in pre-clinical stage development.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Pharmaceutical Medicine Pharmaceuticals Cancer Pipe Branches Of Biology Medical Specialties Clinic Drugs Biopharmaceutical Targeting Therapy Respirator Tumor Medical Research Immunotherapy
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Pharmaceutical Medicine Pharmaceuticals Cancer Pipe Branches Of Biology Medical Specialties Clinic Drugs Biopharmaceutical Targeting Therapy Respirator Tumor Medical Research Immunotherapy
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 364.0 |
| 52 Week Low | 113.0 |
| Average Volume | 36,756 |
| 200-Day Moving Average | 260.17 |
| 50-Day Moving Average | 157.40 |
| 20-Day Moving Average | 133.48 |
| 10-Day Moving Average | 125.30 |
| Average True Range | 12.41 |
| RSI (14) | 31.03 |
| ADX | 28.47 |
| +DI | 11.82 |
| -DI | 30.70 |
| Chandelier Exit (Long, 3 ATRs) | 160.78 |
| Chandelier Exit (Short, 3 ATRs) | 150.22 |
| Upper Bollinger Bands | 152.77 |
| Lower Bollinger Band | 114.18 |
| Percent B (%b) | 0.09 |
| BandWidth | 28.91 |
| MACD Line | -11.44 |
| MACD Signal Line | -11.61 |
| MACD Histogram | 0.1702 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 125.45 | ||||
| Resistance 3 (R3) | 124.83 | 121.57 | 124.13 | ||
| Resistance 2 (R2) | 121.57 | 119.54 | 121.88 | 123.68 | |
| Resistance 1 (R1) | 119.53 | 118.29 | 120.15 | 120.15 | 123.24 |
| Pivot Point | 116.27 | 116.27 | 116.58 | 116.58 | 116.27 |
| Support 1 (S1) | 114.23 | 114.24 | 114.85 | 114.85 | 111.76 |
| Support 2 (S2) | 110.97 | 112.99 | 111.28 | 111.32 | |
| Support 3 (S3) | 108.93 | 110.97 | 110.88 | ||
| Support 4 (S4) | 109.55 |
